天津津燃公用(01265.HK)七成股擬被注入控股股東合營企業津燃華潤
天津津燃公用(01265.HK)公佈,持有公司70.54%股權的控股股東天津燃氣,與華潤燃氣(01193.HK)全資附屬成立合營企業津燃華潤,雙方將分別持有合營企業的51%及49%股權,天津燃氣將以注入其全部天然氣相關業務(其中包括天津燃氣所持有的公司內資股)方式出資,而華潤燃氣將以現金方式出資。
完成後,津燃華潤及其一致行動人士將持有公司已發行股本約70.54%。香港證監會已豁免津燃華潤之要約責任。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.